Brokers Issue Forecasts for ZVRA FY2026 Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Cantor Fitzgerald issued their FY2026 earnings per share estimates for Zevra Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will earn $0.98 per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $25.00 […]
